CNC Centene Corporation

Q1 2025 10-Q

Filed: Apr 25, 2025Period ending Mar 31, 2025

Financials

Hospital & Medical Service PlansSEC EDGAR

Centene Corporation (CNC) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 25, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• New risk from U.S. government tariffs and retaliatory tariffs impacting costs of drugs, devices, and supplies with uncertain amount and duration
• Updated financial risk: revenue timing mismatch with tariff-driven cost increases due to annual pricing of government-sponsored health programs

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$42.5B

▲ +16.9% YoY

Net Income

$1.3B

▲ +12.7% YoY

Gross Margin

12.4%

▼ -59bp YoY

Operating Margin

3.6%

▲ +57bp YoY

Net Margin

3.1%

▼ -12bp YoY

EPS (Diluted)

$2.63

▲ +21.8% YoY

Operating Cash Flow

$1.5B

▲ +431.1% YoY

Source: XBRL data from Centene Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Centene Corporation Quarterly Reports

Q3 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Centene Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.